Journal September 25, 2026 4 min read

How Are Glycosaminoglycans Measured?

Glycosaminoglycans are quantified by colorimetric dye-binding assays, chromatographic separation, and antibody-based detection of proteoglycan core proteins. This page summarises the measurement methods reported in the s

peptides-pro Editorial

Glycosaminoglycans (GAGs) are a class of linear, sulfated or non-sulfated polysaccharides that include heparan sulfate, chondroitin sulfate, dermatan sulfate, keratan sulfate, and hyaluronic acid. They are measured in research settings by colorimetric dye-binding assays, such as the Farndale method, which quantifies total sulfated GAG content; by chromatographic or electrophoretic separation for disaccharide composition; and by immunoassays for specific proteoglycan core proteins, such as decorin or syndecan-1. The evidence block does not provide a molecular formula, sequence, or molecular weight for any GAG.

The work described in the supplied evidence centres on fibroblast growth factor (FGF) signalling, cytokine-driven extracellular matrix (ECM) remodelling, and proteoglycan–microbe interactions, with measurement endpoints including GAG content, decorin secretion, and heparan sulfate fragment release.

Research Studies

Kisspeptin-10 and glycosaminoglycan content in human cardiac fibroblast cultures

In human cardiac fibroblast cultures, kisspeptin-10 (KiSS-10) was reported to regulate glycosaminoglycan and decorin content. Glycosaminoglycan levels were determined by the Farndale method, and decorin secretion was measured by enzyme-linked immunosorbent assay (ELISA). The study used a human cardiac fibroblast cell line and tested the effects of KiSS-10 with or without signalling inhibitors to identify the mechanism [1].

GHK and glycosaminoglycan synthesis in skin models

Glycyl-histidyl-lysine (GHK) is a tripeptide that has been reported to enhance collagen and glycosaminoglycan synthesis in preclinical models. GHK-Cu and palmitoylated GHK (Pal-GHK) are derivatives used in topical anti-wrinkle products. The evidence describes GHK as having tissue regeneration, nerve outgrowth, and angiogenesis properties, but does not specify the measurement method for GAGs in these studies [2].

CACIPLIQ20 and heparan sulfate in epidermolysis bullosa

A clinical trial of CACIPLIQ20 in subjects with epidermolysis bullosa (EB) is registered on ClinicalTrials.gov. The study description notes that heparan sulfates are key elements of the basement membrane zone, and that EB is characterised by fragility of epithelial tissues. The trial is ongoing; no results are reported in the evidence block [3].

Chondroitin sulfate and osteoarthritis burden (TRUST study)

Chondroitin sulfate (CS) is a glycosaminoglycan and a symptomatic slow-acting drug for osteoarthritis (SYSADOA). The TRUST study is an observational, descriptive, prospective national study in Poland designed to describe the burden of osteoarthritis and quality of life in patients treated with Structum® (a chondroitin sulfate product). The evidence does not report GAG measurement methods for this study [4].

Glycocalyx degradation and circulating unmeasured ions after cardiopulmonary bypass

A prospective subanalysis embedded in a randomised trial examined whether endothelial glycocalyx degradation is associated with increased circulating unmeasured ions after cardiopulmonary bypass. The study reports that heparan sulfate fragments are released as part of glycocalyx degradation, and these polyanionic fragments may contribute to the unexplained anionic burden. This is a reference-only item; it supports the page but is not its content [5].

GHK-Cu in aesthetic medicine

A review of GHK-Cu in aesthetic medicine reports that GHK-Cu has demonstrated regenerative, anti-inflammatory, and antioxidant properties in preclinical models. The evidence does not describe specific GAG measurement methods for this compound. This is a reference-only item [6].

Proteoglycans as regulators of bone metastasis

A review on proteoglycans in bone metastasis describes how these molecules regulate extracellular matrix remodelling, tumour–bone crosstalk, and dormancy in cancers such as breast and prostate cancer. The evidence does not provide GAG measurement details. This is a reference-only item [7].

Intestinal epithelial Syndecan-1 and mucosal homeostasis in inflammatory bowel disease

A study on intestinal epithelial Syndecan-1 (SDC1) reports that this proteoglycan maintains mucosal homeostasis in inflammatory bowel disease by enhancing Faecalibacterium prausnitzii biofilm formation. The evidence does not specify how GAG chains were measured. This is a reference-only item [8].

Comparison of measurement methods reported in the evidence

Method	Analyte	Study context	Reference
Farndale method	Total sulfated GAGs	Human cardiac fibroblast cultures treated with KiSS-10	[1]
ELISA	Decorin secretion	Human cardiac fibroblast cultures treated with KiSS-10	[1]
Not specified	GAG synthesis	GHK studies in skin models	[2]
Not specified	Heparan sulfate	Epidermolysis bullosa trial (CACIPLIQ20)	[3]
Not specified	Chondroitin sulfate	Osteoarthritis burden study (TRUST)	[4]
Not specified	Heparan sulfate fragments	Cardiopulmonary bypass subanalysis	[5]

If you are reading this for personal health reasons

The materials described here are sold for laboratory research only. We do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.